More interestingly, tunicamycin not only enhances HER2+ breast cancer cell sensitivity to trastuzumab by inducing cell cycle arrest and apoptosis but also confers endoplasmic reticulum (ER) stress-associated apoptosis induced by ADR and vincristine in GC cells [208,209]. Here, ERBB2 is linked to breast cancer.